Drostagen-100 Rapid Calvin Scott

£65.00

Drostagen-100 Rapid Calvin Scott is a drostanolone propionate compound formulated for advanced research applications. Laboratory-grade preparation designed for comprehensive in-vitro studies examining anabolic research parameters.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Drostagen-100 Rapid Calvin Scott
Drostagen-100 Rapid Calvin Scott
£65.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Drostagen-100 Rapid Calvin Scott — Research Summary

Drostagen-100 Rapid Calvin Scott is a drostanolone propionate formulation manufactured by Calvin Scott for laboratory research applications. This research compound represents a synthetic derivative of dihydrotestosterone, specifically engineered for in-vitro studies examining anabolic and androgenic cellular mechanisms. Researchers investigating steroid biochemistry utilise this compound to analyse molecular interactions within controlled laboratory environments. The formulation provides consistent experimental parameters for studies requiring reliable drostanolone propionate samples. At Stroid UK Shop, we supply this research-grade compound exclusively for scientific investigation purposes.

Laboratory Research Applications

Scientists study Drostagen-100 Rapid to examine cellular responses to synthetic androgenic compounds in controlled research settings. Laboratory protocols investigate how drostanolone propionate influences protein synthesis pathways, cellular growth mechanisms, and hormonal receptor interactions. Researchers analyse the compound’s molecular structure to understand steroid-receptor binding characteristics and downstream cellular signalling cascades. Comparative studies evaluate this formulation against other drostanolone propionate preparations to assess purity and consistency parameters. Advanced research protocols examine metabolic pathways and enzymatic interactions within tissue culture systems. Research teams investigating anabolic mechanisms often compare findings with studies using SARMs compounds to understand selective tissue targeting differences. Some laboratories incorporate this compound into multi-compound research protocols alongside peptides to examine synergistic cellular effects.

Technical Specifications

Drostagen-100 Rapid Calvin Scott Research Specifications
Parameter Specification
Active Compound Drostanolone Propionate
Concentration 100mg/mL
Manufacturer Calvin Scott
Presentation Injectable Solution
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Molecular Weight Verify with supplier
Storage Requirements Cool, dry conditions

Research Use Compliance

Drostagen-100 Rapid Calvin Scott is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this research chemical. All experimental procedures should be conducted by qualified personnel within appropriately equipped laboratory facilities.

Related